AbbVie Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $5.31B | $5.95B | $5.14B | $1.77B | $4.13B | $5.28B | $3.43B |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $425.0M | $425.0M | $417.0M | $383.0M | $388.0M | $525.0M | $508.0M |
| Amortization | $1.08B | $764.0M | $419.0M | $403.0M | $509.0M | $625.0M | $764.0M |
| Stock-Based Compensation | $365.0M | $353.0M | $282.0M | $241.0M | $212.0M | $187.0M | $163.0M |
| Net Cash from Operating Activities | $9.96B | $7.04B | $7.54B | $3.55B | $6.27B | $6.35B | $6.25B |
| Investing Activities | |||||||
| Capital Expenditures | $529.0M | $479.0M | $532.0M | $612.0M | $491.0M | $333.0M | $356.0M |
| Business Acquisitions | $0 | $2.50B | $11.49B | $622.0M | $405.0M | $688.0M | $273.0M |
| Net Cash from Investing Activities | $-274.0M | — | — | — | — | — | — |
| Financing Activities | |||||||
| Dividends Paid | $4.11B | $3.72B | $3.29B | $2.66B | $2.56B | — | — |
| Stock Repurchases | $1.41B | $6.03B | $7.59B | $665.0M | $320.0M | — | — |
| Net Cash from Financing Activities | $-5.51B | $-3.93B | — | — | — | — | — |
| Net Change in Cash | $4.20B | $-3.30B | $51.0M | $-1.25B | $3.69B | — | — |
| Free Cash Flow | $9.43B | $6.56B | $7.00B | $2.94B | $5.78B | $6.01B | $5.89B |